8-K - Q1 2018 EARNINGS RELEASE

Company

Atara Biotherapeutics, Inc.

Filed

May 8, 2018

Period of Report

May 8, 2018

Accession Number

0001564590-18-011459

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →